XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating | ||||||
| Operating Cash Flow | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — |
| Investing | ||||||
| Capital Expenditures | — | — | — | — | 1.1M | 377,000 |
| Acquisitions | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — |
| Financing | ||||||
| Debt Repayment | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — |
| Summary | ||||||
| Free Cash Flow | — | — | — | — | -96.6M | -80.9M |
| Net Change in Cash | — | — | — | — | — | — |